Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Mitochondrial fission and bioenergetics mediate human lung fibroblast durotaxis
Ting Guo, Chun-sun Jiang, Shan-Zhong Yang, Yi Zhu, Chao He, A. Brent Carter, Veena B. Antony, Hong Peng, Yong Zhou
Ting Guo, Chun-sun Jiang, Shan-Zhong Yang, Yi Zhu, Chao He, A. Brent Carter, Veena B. Antony, Hong Peng, Yong Zhou
View: Text | PDF
Research Article Cell biology Pulmonology

Mitochondrial fission and bioenergetics mediate human lung fibroblast durotaxis

  • Text
  • PDF
Abstract

Pulmonary fibrosis is characterized by stiffening of the extracellular matrix. Fibroblasts migrate in the direction of greater stiffness, a phenomenon termed durotaxis. The mechanically guided fibroblast migration could be a crucial step in the progression of lung fibrosis. In this study, we found primary human lung fibroblasts sense increasing matrix stiffness with a change of mitochondrial dynamics in favor of mitochondrial fission and increased production of ATP. Mitochondria polarize in the direction of a physiologically relevant stiffness gradient, with conspicuous localization to the leading edge, primarily lamellipodia and filopodia, of migrating lung fibroblasts. Matrix stiffness–regulated mitochondrial fission and durotactic lung fibroblast migration are mediated by a dynamin-related protein 1/mitochondrial fission factor–dependent (DRP1/MFF-dependent) pathway. Importantly, we found that the DRP1/MFF pathway is activated in fibrotic lung myofibroblasts in both human IPF and bleomycin-induced mouse lung fibrosis. These findings suggest that energy-producing mitochondria need to be sectioned via fission and repositioned in durotactic lung fibroblasts to meet the higher energy demand. This represents a potentially new mechanism through which mitochondria may contribute to the progression of fibrotic lung diseases. Inhibition of durotactic migration of lung fibroblasts may play an important role in preventing the progression of human idiopathic pulmonary fibrosis.

Authors

Ting Guo, Chun-sun Jiang, Shan-Zhong Yang, Yi Zhu, Chao He, A. Brent Carter, Veena B. Antony, Hong Peng, Yong Zhou

×

Figure 1

Stiff matrix promotes mitochondrial fission in primary human lung fibroblasts.

Options: View larger image (or click on image) Download as PowerPoint
Stiff matrix promotes mitochondrial fission in primary human lung fibrob...
Primary human lung fibroblasts were cultured on soft and stiff PA gels for 48 hours. (A) Mitochondria and actin filaments were stained by MitoTracker (red) and phalloidin (green). The binarized mitochondria were converted into topological skeletons. Scale bar = 20 μm. (B) The mean mitochondrial area, number of branches, length of branches, and mean branch length in the skeletonized mitochondrial network were measured by Mitochondria Analyzer plugin in ImageJ (NIH). Bar graphs represent mean ± SD per cell from 30 cells derived from 3 human participants (n = 10 cells per participant) under each condition. (C–J) Relative mRNA levels of DRP1 (C and D), MFF (E and F), FIS1 (G and H), and OPA1 (I and J) were determined by quantitative reverse transcription PCR. GAPDH was used as an internal reference control. Protein levels of DRP1, MFF, FIS1, and OPA1 were determined by immunoblot. GAPDH and VDAC were used as loading controls. Densitometry was performed using ImageJ. Bar graphs represent mean ± SD of experiments from 3–5 independent human participants, each performed in triplicates. A 2-tailed Student’s t test was used for comparison between groups.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts